253 related articles for article (PubMed ID: 15539835)
1. Incidental prostatic cancer: repeat TURP or biopsy?
Martino P; Palazzo S; Battaglia M; Lucarelli G; Selvaggi FP
Urol Int; 2004; 73(3):193-7. PubMed ID: 15539835
[TBL] [Abstract][Full Text] [Related]
2. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era.
Jones JS; Follis HW; Johnson JR
Prostate Cancer Prostatic Dis; 2009; 12(1):57-60. PubMed ID: 18379587
[TBL] [Abstract][Full Text] [Related]
3. Role of transurethral biopsy sampling of the prostate to diagnose prostate cancer in men undergoing surgical intervention for benign prostatic hyperplasia.
Bales GT; Flynn TJ; Kynaston HG; Golash A; Hart A; Kim HL; Gerber GS
Tech Urol; 2000 Sep; 6(3):201-4. PubMed ID: 10963487
[TBL] [Abstract][Full Text] [Related]
4. [Present-day possibilities of prostate cancer screening in patients with benign prostatic hyperplasia before and after surgical treatment].
Pushkar' DIu; Rasner PI; Skobelev PP
Urologiia; 2001; (6):48-54. PubMed ID: 11785083
[No Abstract] [Full Text] [Related]
5. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and treatment of incidental prostate cancer following TUPVP (a report of 15 cases)].
Gu X; Zhu Q; Zhang P; Zhang Y; Lu Z; Xu Y; Huang S
Zhonghua Nan Ke Xue; 2004 Nov; 10(11):849-50, 854. PubMed ID: 15595689
[TBL] [Abstract][Full Text] [Related]
7. PSCA mRNA expression in preoperatively negative prostate biopsies predicts incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Ma W; Zeng G; Qi D
J Surg Oncol; 2011 Nov; 104(6):672-8. PubMed ID: 21674503
[TBL] [Abstract][Full Text] [Related]
8. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
[TBL] [Abstract][Full Text] [Related]
9. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
10. Outcome of radical prostatectomy for incidental carcinoma of the prostate.
Melchior S; Hadaschik B; Thüroff S; Thomas C; Gillitzer R; Thüroff J
BJU Int; 2009 Jun; 103(11):1478-81. PubMed ID: 19076134
[TBL] [Abstract][Full Text] [Related]
11. [Prostatic cancer developing after transurethral resection of the prostate for benign prostatic hyperplasia].
Tanaka Y; Aoyama H; Momose H; Ono T; Samma S; Tanaka N; Akiyama T; Tani Y; Masuda Y; Matsuki H; Tani M; Tanaka M
Hinyokika Kiyo; 2001 Jan; 47(1):11-4. PubMed ID: 11235214
[TBL] [Abstract][Full Text] [Related]
12. High Incidence of Incidental Prostate Cancer in Transurethral Resection of Prostate Specimens in China. The Value of Pathologic Review.
Lin J; Yu X; Yang X; Jin J; Zhou L; Liu L; Su J; Li Y; Shang M
Anal Quant Cytopathol Histpathol; 2016 Feb; 38(1):31-7. PubMed ID: 27363064
[TBL] [Abstract][Full Text] [Related]
13. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
Zhigang Z; Wenlu S
Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of stage a prostatic cancer detected incidentally by transurethral resection of the prostate].
Nakanishi S; Gotou T; Sawada A; Shibasaki N; Ishitoya T; Okumura K
Hinyokika Kiyo; 2009 Jan; 55(1):5-8. PubMed ID: 19227204
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of serum total and free prostate-specific antigen (PSA) after extended multisite prostate biopsy: Comparison among biopsy, transurethral resection of the prostate (TURP), and biopsy plus TURP.
Hara N; Koike H; Nobushita T; Miyajima N; Kawaguchi M; Nishiyama T; Takahashi K; Hohenfellner R
Urol Oncol; 2010; 28(4):355-9. PubMed ID: 19110451
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for incidental prostate cancer-who should not undergo vaporization of the prostate for benign prostate hyperplasia?
Voigt S; Hüttig F; Koch R; Propping S; Propping C; Grimm MO; Wirth M
Prostate; 2011 Sep; 71(12):1325-31. PubMed ID: 21308716
[TBL] [Abstract][Full Text] [Related]
17. Value of prostatic cancer screening in patients treated for benign prostatic hyperplasia with medical or minimally invasive modalities.
Orihuela E; Kocurek JN; Warren MM
Arch Esp Urol; 1997 Sep; 50(7):821-4. PubMed ID: 9350090
[TBL] [Abstract][Full Text] [Related]
18. Prostatic nephrogenic adenoma. Case report.
López Martín L; García Cardoso JV; Martín Vivas C; Gómez Muñoz J; Susaníbar Napurí LF; González Enguita C
Arch Esp Urol; 2011 Jun; 64(5):473-6. PubMed ID: 21705821
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of patients with stage T1b incidental prostate cancer.
Argyropoulos A; Doumas K; Farmakis A; Aristas O; Kontogeorgos G; Lykourinas M
Scand J Urol Nephrol; 2005; 39(4):289-93. PubMed ID: 16118104
[TBL] [Abstract][Full Text] [Related]
20. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
